SecBot SecBot
SECBOTREPLAY Home › Report › TNGX

TNGX · Adam Crystal, an officer of Tango Therapeutics, filed a Form 144 notice…

Tango Therapeutics, Inc. · 144 filed Nov 2, 2026 at 16:37 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 2, 2026 at 16:37 ET

Adam Crystal, an officer of Tango Therapeutics, filed a Form 144 notice of intent to sell 20,000 shares of common stock, valued at approximately $454,400, on November 2, 2026. The shares are to be acquired through the exercise of stock options, and the sale is part of a pre-existing 10b5-1 trading plan, with prior monthly sales of 27,000 shares each in August, September, and October 2026. This is a routine insider sale under a plan, not a discretionary signal.

  • Insider Adam Crystal (Officer) filed Form 144 to sell 20,000 shares of Tango Therapeutics common stock.
  • Estimated sale value: $454,400 (based on $22.72 per share, derived from the filing's total value and share count).
  • Shares to be sold are acquired via exercise of stock options.
  • Sale is part of a 10b5-1 trading plan; prior sales under the same plan: 27,000 shares on 10/01/2026 ($660,797), 09/01/2026 ($603,910), and 08/03/2026 ($735,518).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access